According to Zacks, “Earnings estimates have been stable lately ahead of Morgan Stanley's third-quarter 2016 results. Further, the company has a positive record of earnings surprises in recent quarters. The company’s efforts to offload its non-core assets to lower balance-sheet risks, control expenses and shift focus towards less capital-incentive businesses are commendable. In addition, the company has significantly diversified its footprints and product portfolio. However, equity trading income distress may continue owing to macroeconomic headwinds and lower level of client activity. Further, concerns related to new regulatory requirements and intense pricing competition make us apprehensive. Moreover, increased dependence on structured investment vehicles and commercial mortgage-backed securities may lead to future write-downs if the economy deteriorates.”
A number of other analysts also recently weighed in on MS. Barclays PLC restated a hold rating on shares of Morgan Stanley in a research note on Saturday, July 9th. Deutsche Bank AG restated a hold rating on shares of Morgan Stanley in a research note on Sunday, June 26th. Vetr upgraded Morgan Stanley from a sell rating to a hold rating and set a $26.38 price target on the stock in a research note on Wednesday, July 13th. RBC Capital Markets set a $32.00 price target on Morgan Stanley and gave the company a buy rating in a research note on Thursday, July 21st. Finally, Berenberg Bank started coverage on Morgan Stanley in a research note on Wednesday, July 13th. They issued a hold rating and a $29.00 price target on the stock. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and fourteen have issued a buy rating to the stock. The stock presently has a consensus rating of Hold and a consensus price target of $32.41.
Shares of Morgan Stanley (NYSE:MS) traded down 0.96% during mid-day trading on Thursday, hitting $32.08. The company’s stock had a trading volume of 4,653,552 shares. The company has a market cap of $61.33 billion, a PE ratio of 14.84 and a beta of 2.09. The stock has a 50-day moving average of $31.61 and a 200-day moving average of $27.95. Morgan Stanley has a 12-month low of $21.16 and a 12-month high of $35.74.
Morgan Stanley (NYSE:MS) last posted its quarterly earnings results on Wednesday, July 20th. The financial services provider reported $0.75 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.59 by $0.16. Morgan Stanley had a return on equity of 6.41% and a net margin of 13.27%. The firm had revenue of $8.91 billion for the quarter, compared to the consensus estimate of $8.30 billion. During the same period in the previous year, the business earned $0.79 earnings per share. The company’s revenue for the quarter was down 8.6% compared to the same quarter last year. On average, equities research analysts forecast that Morgan Stanley will post $2.50 EPS for the current year.
In related news, major shareholder Stanley Morgan sold 357 shares of the stock in a transaction dated Tuesday, September 27th. The stock was sold at an average price of $23,750.00, for a total value of $8,478,750.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jeffrey S. Brodsky sold 19,955 shares of the stock in a transaction dated Thursday, July 21st. The shares were sold at an average price of $28.79, for a total value of $574,504.45. Following the completion of the transaction, the insider now directly owns 123,710 shares of the company’s stock, valued at approximately $3,561,610.90. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of MS. FineMark National Bank & Trust increased its position in shares of Morgan Stanley by 2.0% in the second quarter. FineMark National Bank & Trust now owns 4,332 shares of the financial services provider’s stock worth $113,000 after buying an additional 84 shares in the last quarter. Assetmark Inc. increased its position in shares of Morgan Stanley by 291.1% in the second quarter. Assetmark Inc. now owns 5,323 shares of the financial services provider’s stock worth $138,000 after buying an additional 3,962 shares in the last quarter. Synovus Financial Corp increased its position in shares of Morgan Stanley by 11.3% in the second quarter. Synovus Financial Corp now owns 5,418 shares of the financial services provider’s stock worth $141,000 after buying an additional 549 shares in the last quarter. Acrospire Investment Management LLC increased its position in shares of Morgan Stanley by 100.0% in the second quarter. Acrospire Investment Management LLC now owns 6,200 shares of the financial services provider’s stock worth $161,000 after buying an additional 3,100 shares in the last quarter. Finally, Handelsbanken Fonder AB acquired a new position in shares of Morgan Stanley during the second quarter worth approximately $205,000. 83.64% of the stock is owned by hedge funds and other institutional investors.
Morgan Stanley Company Profile
Morgan Stanley is a financial holding company. The Company is a global financial services firm that, through its subsidiaries and affiliates, advises, and originates, trades, manages and distributes capital for, governments, institutions and individuals. Its segments include Institutional Securities, Wealth Management and Investment Management.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.